Optimal use of pegvisomant in acromegaly: are we getting there?
- PMID: 25348149
- DOI: 10.1007/s12020-014-0462-0
Optimal use of pegvisomant in acromegaly: are we getting there?
Comment on
-
ACROSTUDY: the Italian experience.Endocrine. 2015 Feb;48(1):334-41. doi: 10.1007/s12020-014-0393-9. Epub 2014 Aug 23. Endocrine. 2015. PMID: 25150035
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources